We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medidata releases Patient Profiles consulting service

Medidata releases Patient Profiles consulting service

December 10, 2014
CenterWatch Staff

Medidata, a New York-based global provider of cloud-based solutions for clinical research in life sciences, has made available its enriched solution for risk-based monitoring (RBM) of clinical trial sites. The company’s previously announced acquisition of Patient Profiles, an early stage software company focused on improving clinical trial data quality, broadens Medidata’s best-in-class technology for RBM, a methodology for reducing trial costs while providing clinical data accuracy and quality.

Founded by two former FDA statistical reviewers, Barbara Elashoff and Michael Elashoff, Patient Profiles now is available as a consulting service to Medidata customers. The Patient Profiles offering adds visualized monitoring analytics around subject and site data, providing immediate insight into clinical trial site performance and data quality. Its user-friendly software platform utilizes proprietary algorithms to predict where data errors may occur during studies, and then automatically adjusts risk indicators to allow for early detection of anomalies and outliers in clinical data—including potential fraud and misconduct.

The Patient Profiles offering will be integrated into the Medidata Clinical Cloud as part of Medidata RBM. A comprehensive, systematic approach to risk-based monitoring, Medidata RBM includes a robust combination of technology, analytics and hands-on strategic consulting services that enable life science organizations to quickly realize the quality, cost and timeline benefits of a RBM program. Through the automated review of clinical data captured in Medidata’s cloud-based electronic data capture and management system (Medidata Rave), the addition of Patient Profiles makes Medidata RBM the first cloud-based solution to provide centralized monitoring analytics using both operational data (e.g., key risk indicators, such as adverse event rates and query cycle times) and patient data.

“With its focus on centralized monitoring, Patient Profiles complements our existing risk-based monitoring offering by providing a set of tools to help monitoring teams be more targeted in their approach and identify anomalies in clinical data,” said Glen de Vries, Medidata’s president.

Along with its capabilities around site performance and data quality, the Patient Profiles offering also includes a highly configurable reporting tool that integrates data points from disparate sources and organizes them into individual patientcentric reports. The reports make it easier for clinical teams to detect critical data changes, such as those that may indicate potential adverse events.

“Risk-based monitoring is such a key area for Medidata and the industry because of its ability to improve data quality and lower monitoring costs,” de Vries added. “Integrating Patient Profiles into our platform is part of our focus on continual innovation and further enhances our easy-to-use, holistic RBM offering, which is helping sponsors and their CRO partners improve operational efficiencies and decision making throughout the clinical trial lifecycle.”

United States Technology Solutions
  • Related Directories

    Complion

    IRBNet

    CROMSOURCE

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing